Recorded Chinese product: 盐酸氟西汀片盐酸氟西汀片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 常州四药制药有限公司Chinese legal name: 常州四药制药有限公司
主要成分Active Ingredients
- 氟西汀Fuxi Ting
药物知识说明
氟西汀是一种在国家药监局注册认定的药品。该药品含有氟西汀-1f601b33等成分。
该药品关联的活性成分包括：氟西汀Fuxi Ting。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：常州四药制药有限公司Chinese legal name: 常州四药制药有限公司。
您可以探索含有相同成分的其他药品：氟西汀-1f601b33成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 盐酸氟西汀片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 氟西汀Fuxi Ting.
Manufacturers recorded for this product: 常州四药制药有限公司Chinese legal name: 常州四药制药有限公司.
Explore other medicines containing the same ingredient: 氟西汀 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 盐酸氟西汀片Recorded Chinese product: 盐酸氟西汀片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 10mg*14片10 mg × 14 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 常州四药制药有限公司Chinese legal name: 常州四药制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H19980139
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H19980139
Manufacturer
Chinese legal name: 常州四药制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
10 mg × 14 tablets
中文说明书原文Original Chinese source label
批准文号
国药准字H19980139
生产企业
常州四药制药有限公司(国产)
适应症
本品适用于各种抑郁性精神障碍。包括轻性或重性抑郁症，双相情感性精神病。
用法用量
一般只需每天早上一次口服20mg(2片)，必要时可加至每天40mg(4片)。剂量和疗程遵医嘱。
不良反应
1.常见不良反应为口干、食欲减退、恶心、失眠、乏力。
2.少数病例可见焦虑、头痛。
禁忌
禁用于已知对此药过敏者。
注意事项
1.因本药半衰期较长，故肝，肾功能较差者或老年病人，应适当减少剂量。
2.妊娠或哺乳妇女慎用。
3.儿童应用时应遵医嘱。
4.如出现皮疹或发热，应立即停药，并对症处理。不
5.宜与单胺氧化酶抑制剂（MAOI）并用。
6.必要时，应停用本药5周后，才可换用单胺氧化酶抑制剂（MAOI）。
贮藏
遮光，密封，在阴凉干燥处保存。
规格
10mg*14片
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.